Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

Pneumonia

Risk Factors of 30-Day Mortality in Acinetobacter baumannii Complex Bacteremia

Estie Mermelstein, MSN, FNP-BC

September 16, 2022

Researchers assessed potential risk factors associated with 30-day mortality among patients with Acinetobacter baumannii complex bacteremia.

General Pulmonology

Long COVID: Potential Risk Factors Identified via Analysis of Documented Care

Estie Mermelstein, MSN, FNP-BC

September 9, 2022

Researchers evaluated patients with documented care for long COVID to determine factors associated with its occurrence.

General Medicine

Machine Learning Model Predicts COVID-19 Severity With Laboratory Data

Estie Mermelstein, MSN, FNP-BC

September 7, 2022

Researchers evaluated the accuracy of machine learning models to predict COVID-19 severity on the basis of patient characteristics and laboratory data.

bald man in hospital bed receiving oxygen

Pneumonia

Normal Oxygen Saturation in Pneumonia May Indicate Safety of Early Antibiotic Discontinuation

Estie Mermelstein, MSN, FNP-BC

September 6, 2022

Researchers assessed whether normal oxygenation is an indicator for the early discontinuation of antibiotic treatment in patients hospitalized with pneumonia.

Influenza

Safety, Immunogenicity of a Novel Adjuvanted Influenza Vaccine

Estie Mermelstein, MSN, FNP-BC

August 23, 2022

Researchers assessed the safety and immunogenicity of a novel seasonal influenza vaccine adjuvanted with hydroxypropropyl-β-cyclodextrin.

Erythema nodosum (EN) is characterized by inflammation of subcutaneous fat cells.3 The condition is 3 to 6 times more common in women and typically occurs between age 25 and 40.14 Pregnancy is the cause of erythema nodosum (EN) in an estimated 2% to 6% of cases.2 Other causes include infection (especially streptococcal), sarcoidosis, and malignancy.14 During pregnancy, EN typically begins in the first trimester or early in the second trimester.2 Erythema nodosum is characterized by spontaneous eruption of firm red, tender, painful nodules on the lower legs (usually the shins) and occasionally on the forearms and thighs.3,14 The nodules typically reach 10 to 40 mm in diameter.12 Accompanying symptoms may include fever, ankle edema, and joint or abdominal pain.14 Most cases of EN resolve spontaneously within 4 to 8 weeks of onset.3,14 Compression stockings, bed rest with leg elevation, and analgesics can help with discomfort.2,3

General Pulmonology

Erythema Nodosum Linked to Better Prognosis in Patients With Sarcoidosis

Estie Mermelstein, MSN, FNP-BC

August 11, 2022

The clinical characteristics and treatment-related features in patients with sarcoidosis are compared based on if EN was a presenting symptom at the time of diagnosis.

General Medicine

Dexamethasone vs Methylprednisolone in Patients Hospitalized With COVID-19

Estie Mermelstein, MSN, FNP-BC

August 5, 2022

Researchers compared the effects of dexamethasone with methylprednisolone in patients hospitalized with COVID-19 infection.

Lung Infection

Testing for Respiratory Pathogens Does Not Decrease Antibiotic Use in Children

Estie Mermelstein, MSN, FNP-BC

August 1, 2022

Researchers assessed whether point-of-care multiplex polymerase chain reaction testing for respiratory pathogens decreases the rate of untargeted antibiotic therapy in children.

General Medicine

Corticosteroids Decrease Mortality Risk in Patients With Severe COVID-19

Estie Mermelstein, MSN, FNP-BC

July 6, 2022

Researchers assessed the efficacy of corticosteroids for the treatment of COVID-19 infection.

Pneumonia

Effect of Urinary Antigen Testing on Antibiotic Guidance for Community-Acquired Pneumonia

Estie Mermelstein, MSN, FNP-BC

June 30, 2022

Researchers assessed whether antibiotic treatment differed on the basis of pneumococcal urinary antigen test results among patients hospitalized with community-acquired pneumonia.

Next post in Pneumonia